These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6148215)

  • 1. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin.
    Kaminsky LS; Dunbar DA; Wang PP; Beaune P; Larrey D; Guengerich FP; Schnellmann RG; Sipes IG
    Drug Metab Dispos; 1984; 12(4):470-7. PubMed ID: 6148215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin.
    Kaminsky LS; Guengerich FP
    Eur J Biochem; 1985 Jun; 149(3):479-89. PubMed ID: 3924614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations.
    Lawrence RF; Rettie AE; Eddy AC; Trager WF
    Chirality; 1990; 2(2):96-105. PubMed ID: 2400642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
    Beaune PH; Kremers PG; Kaminsky LS; De Graeve J; Albert A; Guengerich FP
    Drug Metab Dispos; 1986; 14(4):437-42. PubMed ID: 2873991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
    Miller KK; Cai J; Ripp SL; Pierce WM; Rushmore TH; Prough RA
    Drug Metab Dispos; 2004 Mar; 32(3):305-13. PubMed ID: 14977864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe.
    Zhang Z; Fasco MJ; Huang Z; Guengerich FP; Kaminsky LS
    Drug Metab Dispos; 1995 Dec; 23(12):1339-46. PubMed ID: 8689941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component-purified cytochrome P-450 isozymes.
    Kaminsky LS; Guengerich FP; Dannan GA; Aust SD
    Arch Biochem Biophys; 1983 Aug; 225(1):398-404. PubMed ID: 6311109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and developmental diversity of hepatic cytochromes P450. Warfarin and progesterone metabolism by hepatic microsomes from four inbred strains of rat.
    Kitareewan S; Walz FG
    Drug Metab Dispos; 1994; 22(4):607-15. PubMed ID: 7956737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
    McManus ME; Hall PD; Stupans I; Brennan J; Burgess W; Robson R; Birkett DJ
    Mol Pharmacol; 1987 Aug; 32(1):189-94. PubMed ID: 3112555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.
    Rettie AE; Eddy AC; Heimark LD; Gibaldi M; Trager WF
    Drug Metab Dispos; 1989; 17(3):265-70. PubMed ID: 2568906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective metabolism of cisapride and enantiomer-enantiomer interaction in human cytochrome P450 enzymes: major role of CYP3A.
    Desta Z; Soukhova N; Morocho AM; Flockhart DA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):508-20. PubMed ID: 11454912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
    Kaminsky LS; de Morais SM; Faletto MB; Dunbar DA; Goldstein JA
    Mol Pharmacol; 1993 Feb; 43(2):234-9. PubMed ID: 8429826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
    Pohl LR; Bales R; Trager WF
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin.
    Kunze KL; Eddy AC; Gibaldi M; Trager WF
    Chirality; 1991; 3(1):24-9. PubMed ID: 2039681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.
    Hermans JJ; Thijssen HH
    Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone.
    Surapaneni SS; Clay MP; Spangle LA; Paschal JW; Lindstrom TD
    Drug Metab Dispos; 1997 Dec; 25(12):1383-8. PubMed ID: 9394028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.
    Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
    He M; Kunze KL; Trager WF
    Drug Metab Dispos; 1995 Jun; 23(6):659-63. PubMed ID: 7587949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.